NaNots : Treating Major Diseases with Subtractive Nanoparticles

Drug development has historically progressed in waves . . .

First Wave


Sometimes offers some benefits – which is why it’s still used today.


Side effects include secondary malignancies and immune system damage.
Effects are dose-limiting; patients often can’t handle enough treatment for cure.

 

Second Wave


These “Checkpoint inhibitors” can sometimes induce regression

by blocking the “off switch” on killer T-cells.


Blocking these receptors disrupts immune balance and leads to autoimmunity,
including risk of nephritis, pneumonitis, colitis, hepatitis, etc. Also dose-limiting.

 

Third Wave

Fix Aberrant Signal Flow

For most diseases,
the problem is not bad cells or tissues,
nor a weak immune system.

The problem is incorrect
molecular signals between cells.

Correcting aberrant signal flow,
especially to and from immune cells,
is the future of medicine.

Learn more about how NaNots will impact your world…

FOR SCIENTISTS
FOR ENGINEERS
FOR INVESTORS